Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-23-001517
Filing Date
2023-01-12
Accepted
2023-01-12 17:37:05
Documents
1
Period of Report
2023-01-11

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3418
  Complete submission text file 0001140361-23-001517.txt   4961
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5130 ROUTE 212 WILLOW NY 12495
Business Address
MANUSO JAMES S J (Reporting) CIK: 0001236365 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 23526726